Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADUS Addus HomeCare	$113.79 -1.2%	$108.91	$88.96 ▼ $136.72	$2.09B	0.81	170,637 shs	195,824 shs
ARDT Ardent Health	$13.03 +0.5%	$13.67	$11.31 ▼ $20.72	$1.87B	N/A	383,490 shs	339,801 shs
FLGT Fulgent Genetics	$19.53 -3.8%	$19.84	$14.57 ▼ $25.11	$594.56M	1.06	286,006 shs	408,827 shs
PGNY Progyny	$20.98 -3.1%	$21.87	$13.39 ▼ $30.42	$1.80B	1.32	1.71 million shs	1.75 million shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADUS Addus HomeCare	0.00%	+0.88%	+2.03%	+26.67%	-4.62%
ARDT Ardent Health	0.00%	-0.88%	-12.09%	-1.06%	+1,302,499,900.00%
FLGT Fulgent Genetics	0.00%	-5.61%	-4.82%	+14.28%	-1.26%
PGNY Progyny	0.00%	-0.24%	+0.43%	-4.03%	-18.46%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ADUS Addus HomeCare	4.7782 of 5 stars	3.6	2.0	5.0	2.9	2.5	2.5
ARDT Ardent Health	2.6082 of 5 stars	3.5	0.0	0.0	0.0	0.0	3.1
FLGT Fulgent Genetics	3.9188 of 5 stars	2.3	4.0	4.1	2.1	3.3	0.6
PGNY Progyny	1.6324 of 5 stars	2.2	1.0	0.0	2.7	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ADUS Addus HomeCare	3.25	Buy	$142.57	25.29% Upside
ARDT Ardent Health	3.00	Buy	$20.67	58.67% Upside
FLGT Fulgent Genetics	2.50	Moderate Buy	$24.00	22.89% Upside
PGNY Progyny	2.42	Hold	$23.45	11.79% Upside

Current Analyst Ratings Breakdown

Latest FLGT, PGNY, ADUS, and ARDT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/20/2025	ADUS Addus HomeCare	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$150.00
6/10/2025	ADUS Addus HomeCare	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$133.00
5/20/2025	ARDT Ardent Health	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$21.00 ➝ $21.00
5/15/2025	ARDT Ardent Health	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$21.00 ➝ $21.00
5/12/2025	PGNY Progyny	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$23.00 ➝ $21.00
5/9/2025	ARDT Ardent Health	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$16.00 ➝ $18.00
5/8/2025	ADUS Addus HomeCare	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$129.00 ➝ $133.00
5/6/2025	FLGT Fulgent Genetics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$16.00 ➝ $23.00
5/5/2025	FLGT Fulgent Genetics	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$24.00 ➝ $25.00
4/22/2025	ADUS Addus HomeCare	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$150.00 ➝ $150.00
4/10/2025	ADUS Addus HomeCare	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$150.00 ➝ $150.00

(Data available from 6/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ADUS Addus HomeCare	$1.15B	1.81	$5.39 per share	21.11	$53.52 per share	2.13
ARDT Ardent Health	$5.97B	0.31	$2.53 per share	5.14	$10.66 per share	1.22
FLGT Fulgent Genetics	$283.47M	2.10	N/A	N/A	$36.92 per share	0.53
PGNY Progyny	$1.17B	1.54	$0.35 per share	60.79	$4.96 per share	4.23

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ADUS Addus HomeCare	$73.60M	$4.43	25.69	21.23	1.61	6.52%	9.23%	6.96%	8/4/2025 (Estimated)
ARDT Ardent Health	$210.34M	$1.63	7.99	6.65	1.18	3.73%	16.07%	4.69%	8/13/2025 (Estimated)
FLGT Fulgent Genetics	-$42.71M	-$1.33	N/A	N/A	N/A	-13.94%	-2.19%	-2.02%	8/1/2025 (Estimated)
PGNY Progyny	$54.34M	$0.57	36.81	32.28	2.21	4.33%	10.90%	7.20%	8/5/2025 (Estimated)

Latest FLGT, PGNY, ADUS, and ARDT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/8/2025	Q1 2025	PGNY Progyny	$0.45	$0.17	-$0.28	$0.17	$307.86 million	$324.04 million
5/6/2025	Q1 2025	ARDT Ardent Health	$0.21	$0.29	+$0.08	$0.29	$1.50 billion	$1.50 billion
5/5/2025	Q1 2025	ADUS Addus HomeCare	$1.33	$1.42	+$0.09	$1.16	$341.66 million	$337.71 million
5/2/2025	Q1 2025	FLGT Fulgent Genetics	-$0.18	$0.04	+$0.22	-$0.37	$71.26 million	$73.46 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ADUS Addus HomeCare	N/A	N/A	N/A	N/A	N/A
ARDT Ardent Health	N/A	N/A	N/A	N/A	N/A
FLGT Fulgent Genetics	N/A	N/A	N/A	N/A	N/A
PGNY Progyny	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ADUS Addus HomeCare	0.20	1.74	1.74
ARDT Ardent Health	0.70	2.12	1.98
FLGT Fulgent Genetics	N/A	6.32	6.32
PGNY Progyny	N/A	2.39	2.39

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ADUS Addus HomeCare	95.35%
ARDT Ardent Health	N/A
FLGT Fulgent Genetics	48.06%
PGNY Progyny	94.93%

Insider Ownership

Company	Insider Ownership
ADUS Addus HomeCare	4.60%
ARDT Ardent Health	1.70%
FLGT Fulgent Genetics	33.11%
PGNY Progyny	9.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ADUS Addus HomeCare	49,703	18.40 million	17.55 million	Optionable
ARDT Ardent Health	24,900	143.04 million	140.61 million	Optionable
FLGT Fulgent Genetics	1,313	30.44 million	20.36 million	Optionable
PGNY Progyny	310	85.72 million	77.66 million	Optionable

FLGT, PGNY, ADUS, and ARDT Headlines

Recent News About These Companies

Progyny (PGNY) Soared on Expanding Client Base and Improving Utilization Trends

June 18, 2025 | msn.com

Fort Washington Investment Advisors Inc. OH Reduces Stake in Progyny, Inc. (NASDAQ:PGNY)

June 13, 2025 | marketbeat.com

GAMMA Investing LLC Acquires 118,556 Shares of Progyny, Inc. (NASDAQ:PGNY)

June 13, 2025 | marketbeat.com

Cheryl Scott Sells 2,675 Shares of Progyny, Inc. (NASDAQ:PGNY) Stock

June 12, 2025 | marketbeat.com

Progyny Stock Trades Higher On Collaboration With Amazon’s Health Benefits Connector: Retail’s Yet To Be Impressed

June 10, 2025 | msn.com

Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution

June 10, 2025 | finance.yahoo.com

Progyny Joins Amazon's Health Benefits Connector Program as First Women's Health and Family Building Solution

June 10, 2025 | globenewswire.com

Here’s Why Progyny (PGNY) Rebounded in Q1

June 9, 2025 | msn.com

Olstein Capital Management L.P. Buys New Shares in Progyny, Inc. (NASDAQ:PGNY)

June 9, 2025 | marketbeat.com

Progyny, Inc. (NASDAQ:PGNY) Shares Acquired by NBC Securities Inc.

June 6, 2025 | marketbeat.com

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Lowers Stock Position in Progyny, Inc. (NASDAQ:PGNY)

June 5, 2025 | marketbeat.com

Progyny, Inc. (NASDAQ:PGNY) Stock Position Lessened by Wellington Management Group LLP

June 4, 2025 | marketbeat.com

Leibman Financial Services Inc. Sells 18,076 Shares of Progyny, Inc. (NASDAQ:PGNY)

June 3, 2025 | marketbeat.com

Progyny, Inc. (NASDAQ:PGNY) Given Consensus Recommendation of "Hold" by Brokerages

June 3, 2025 | marketbeat.com

Mackenzie Financial Corp Boosts Stock Position in Progyny, Inc. (NASDAQ:PGNY)

June 1, 2025 | marketbeat.com

Progyny, Inc. (NASDAQ:PGNY) Shares Purchased by Nuveen Asset Management LLC

June 1, 2025 | marketbeat.com

Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors

May 29, 2025 | globenewswire.com

Progyny’s SWOT analysis: fertility benefits firm faces growth challenges

May 29, 2025 | investing.com

Insider Decision Unfolding At Progyny: Elizabeth Bierbower Exercises Options, Resulting In $0

May 29, 2025 | benzinga.com

Major Update: DEBRA MORRIS At Progyny Exercises Options, Realizing $0

May 29, 2025 | benzinga.com

Ameriprise Financial Inc. Trims Stock Position in Progyny, Inc. (NASDAQ:PGNY)

May 29, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

FLGT, PGNY, ADUS, and ARDT Company Descriptions

Addus HomeCare NASDAQ:ADUS

$113.79 -1.37 (-1.19%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$114.60 +0.81 (+0.72%)

As of 06/20/2025 05:01 PM Eastern

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

Ardent Health NYSE:ARDT

$13.02 +0.07 (+0.50%)

Closing price 06/20/2025 03:59 PM Eastern

Extended Trading

$13.04 +0.01 (+0.12%)

As of 06/20/2025 04:12 PM Eastern

Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Fulgent Genetics NASDAQ:FLGT

$19.53 -0.77 (-3.79%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$19.56 +0.02 (+0.13%)

As of 06/20/2025 06:25 PM Eastern

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.

Progyny NASDAQ:PGNY

$20.98 -0.67 (-3.09%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$20.96 -0.02 (-0.10%)

As of 06/20/2025 07:55 PM Eastern

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time